StockTipsArenaBeta

BUY GlaxoSmithKline Pharmaceuticals Limited — Kush Bohra

BUYGlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals share price target & all analyst calls

byKush BohraHorizon: NA (inferred Swing (≤2wk))23 Jul 2026via NDTV Profit

Entry₹2,552.8Inferred
Target₹2,725
Total upside +6.75% (call closed)
Stop loss₹2,470-3.24% risk
Exit₹2,47024 Jul 2026, 10:00 am
Stop-loss hit-3.24%
Follow Kush Bohra for new calls(32% target hit, 186 closed calls)Get alertsWatch GLAXO for new buy/sell callsGet alertsSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Jul 2026
3 supporting0 opposing
Supports the BUY call (3)

Nestle, GSK Pharma Show Momentum as Market Faces Pressure

NewsGoogle News·23 Jul · yesterday

(opens in new tab)

Nestle, GSK Pharma में तेजी के संकेत, गिरावट में बाजार

NewsGoogle News·23 Jul · yesterday

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Jul · 2d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on GlaxoSmithKline Pharmaceuticals

All analyst calls on GlaxoSmithKline Pharmaceuticals

More from Kush Bohra

Every call and its outcome